High Yield/Impactful Articles


Study Design

Understanding RCTs
Take Home Message: Randomization, allocation concealment, and blinded outcome assessment help readers judge whether a trial’s treatment effect is credible and applicable.

How to Read a Meta-Analysis
Take Home Message: Interpret pooled effects alongside study quality, heterogeneity, and confidence intervals before applying a meta-analysis to patient care.


Sedation

Daily interruption of sedation
Take Home Message: Daily interruption of continuous sedative infusions shortened mechanical ventilation and ICU stay compared with clinician-directed interruption in this single-center trial.

SLEAP
Take Home Message: Adding daily sedation interruption to protocolized light sedation did not shorten time to extubation and increased sedative exposure and nursing workload.

MIND-USA
Take Home Message: Haloperidol and ziprasidone did not increase days alive without delirium or coma compared with placebo in critically ill patients with acute respiratory failure or shock.

NONSEDA
Take Home Message: A strategy of no sedation did not improve 90-day survival compared with light sedation with daily interruption in mechanically ventilated patients.

MENDS-2
Take Home Message: Dexmedetomidine and propofol produced similar days alive without delirium or coma in mechanically ventilated adults with sepsis managed with light sedation.

AID-ICU (2023)
Take Home Message: Haloperidol did not significantly increase days alive and out of hospital at 90 days in ICU patients with delirium, despite lower mortality in a secondary analysis.


Stroke

DAWN
Take Home Message: Thrombectomy improved 90-day functional outcomes in selected patients with anterior-circulation large-vessel stroke and a clinical-imaging mismatch presenting 6 to 24 hours after last known well.

DESTINY (hemicrani)
Take Home Message: Early decompressive hemicraniectomy improved survival after malignant middle cerebral artery infarction, but this small trial did not establish a significant benefit for its primary functional endpoint.

RESCUE Japan
Take Home Message: Endovascular therapy improved functional outcomes in selected patients with large ischemic cores, while increasing intracranial hemorrhage.


Resuscitation after Cardiac Arrest

HACA
Take Home Message: Cooling to 32–34°C improved neurologic outcomes and reduced mortality compared with the usual care of that era after witnessed ventricular-fibrillation cardiac arrest.

TTM
Take Home Message: Targeting 33°C did not improve survival or neurologic outcomes compared with 36°C after out-of-hospital cardiac arrest.

TTM2
Take Home Message: Targeting 33°C did not improve survival or functional outcomes compared with targeted normothermia and early fever treatment after out-of-hospital cardiac arrest.

HYPERION
Take Home Message: Targeting 33°C modestly increased survival with favorable neurologic function at 90 days after nonshockable cardiac arrest, without a significant mortality benefit.

CAPITAL CHILL
Take Home Message: Cooling to 31°C did not improve the composite of death or poor neurologic outcome compared with 34°C after out-of-hospital cardiac arrest.

ARREST
Take Home Message: An ECMO-facilitated resuscitation strategy improved survival to hospital discharge after refractory ventricular fibrillation in this small, single-center trial stopped early.

Tracheal intubation and survival
Take Home Message: Tracheal intubation during in-hospital cardiac arrest was associated with lower survival in a time-matched observational analysis, which cannot establish causation.

INCEPTION
Take Home Message: Early extracorporeal CPR did not significantly improve 30-day survival with favorable neurologic function compared with conventional CPR in refractory out-of-hospital arrest.


Postop CT Surgery and Mechanical Circulatory Support

MOMENTUM 3
Take Home Message: The fully magnetically levitated HeartMate 3 improved two-year survival free of disabling stroke or pump replacement compared with the axial-flow HeartMate II.

Rate vs rhythm control for a.fib. after cardiac surgery
Take Home Message: Rate and rhythm control produced similar hospital days and clinical outcomes in hemodynamically stable patients with new atrial fibrillation after cardiac surgery.

VANCS
Take Home Message: Vasopressin reduced the composite of death or severe complications compared with norepinephrine for postcardiac-surgery vasoplegic shock in this single-center trial.

ADVOR
Take Home Message: Adding intravenous acetazolamide to loop diuretics increased successful early decongestion in acute heart failure without a demonstrated reduction in death or heart-failure readmission.

DanGer Shock
Take Home Message: A microaxial flow pump reduced 180-day mortality in selected patients with STEMI-related cardiogenic shock but increased serious adverse events and renal-replacement therapy.


Resuscitation/Sepsis

Goal-directed sepsis resuscitation

EGDT (Rivers et al)
Take Home Message: Early goal-directed therapy reduced in-hospital mortality compared with usual care in this single-center trial of severe sepsis and septic shock.

PROCESS
Take Home Message: Protocol-based early goal-directed therapy did not improve survival compared with other protocolized care or contemporary usual care in septic shock.

ProMISe
Take Home Message: Early goal-directed therapy did not improve 90-day survival compared with contemporary usual care for septic shock and increased treatment intensity and costs.

ARISE
Take Home Message: Early goal-directed therapy did not improve 90-day survival compared with contemporary usual care for early septic shock.


MAP Targets/Vasopressor Strategies

SEPSISPAM
Take Home Message: Targeting a MAP of 80–85 rather than 65–70 mm Hg did not improve septic-shock survival and increased atrial fibrillation, although patients with chronic hypertension required less dialysis.

65 trial
Take Home Message: A MAP target of 60–65 mm Hg reduced vasopressor exposure without a statistically significant difference in 90-day mortality among older patients with vasodilatory hypotension.

ANDROMEDA-SHOCK
Take Home Message: Capillary-refill-guided resuscitation did not significantly reduce the primary outcome of 28-day mortality compared with lactate-guided resuscitation in septic shock.

VASST
Take Home Message: Low-dose vasopressin did not significantly reduce overall mortality compared with norepinephrine in patients with septic shock.

Association Between US Norepinephrine Shortage and Mortality
Take Home Message: A US norepinephrine shortage was associated with increased septic-shock mortality and greater use of alternative vasopressors, without establishing which substitution caused harm.


IV Fluid Volume Management

FEAST
Take Home Message: Albumin or saline boluses increased mortality compared with no bolus in African children with severe febrile illness and impaired perfusion, limiting extrapolation to other settings.

Low vs high volume meta-analysis
Take Home Message: This meta-analysis found very low-certainty evidence and no clear mortality difference between lower and higher initial fluid volumes in adults with sepsis.

CLASSIC
Take Home Message: Restricting intravenous fluids after initial resuscitation did not reduce 90-day mortality compared with standard fluid therapy in ICU patients with septic shock.

CLOVERS
Take Home Message: An early restrictive-fluid strategy prioritizing vasopressors did not improve survival compared with a liberal-fluid strategy for sepsis-induced hypotension after initial fluids.


IV Fluid Choice

SAFE
Take Home Message: Albumin and saline produced similar overall 28-day mortality in a broad ICU population, without establishing equivalence in every diagnostic subgroup.

SMART
Take Home Message: Balanced crystalloids modestly reduced the composite of death, new dialysis, or persistent renal dysfunction compared with saline in critically ill adults.

CRISTAL
Take Home Message: Colloids did not significantly reduce the primary outcome of 28-day mortality compared with crystalloids in hypovolemic shock, despite a secondary 90-day survival signal.

ALBIOS
Take Home Message: Adding albumin to crystalloids did not improve 28- or 90-day survival overall in patients with severe sepsis or septic shock.

HES vs. saline
Take Home Message: Hydroxyethyl starch did not improve survival compared with saline and increased the use of renal-replacement therapy in critically ill patients.

FLUID
Take Home Message: Hospital-wide use of lactated Ringer’s rather than saline did not significantly reduce death or hospital readmission within 90 days.


Adjunct Shock Therapy: Steroids, HAT, Vitamin C

Original Annane trial
Take Home Message: Hydrocortisone plus fludrocortisone reduced mortality in the prespecified subgroup of septic-shock patients who did not respond to corticotropin in this trial.

CORTICUS
Take Home Message: Hydrocortisone hastened shock reversal but did not improve survival in septic shock, including among patients without a corticotropin response.

ADRENAL
Take Home Message: Hydrocortisone accelerated shock resolution but did not reduce 90-day mortality in mechanically ventilated patients with septic shock.

APROCCHSS
Take Home Message: Hydrocortisone plus fludrocortisone reduced 90-day mortality compared with placebo in patients with septic shock.

VITAMINS
Take Home Message: Adding vitamin C and thiamine to hydrocortisone did not increase time alive and free of vasopressors compared with hydrocortisone alone in septic shock.

LOVIT (Vitamin C)
Take Home Message: Intravenous vitamin C increased the risk of death or persistent organ dysfunction at 28 days in adults with sepsis receiving vasopressors.

Evaluation of Etomidate use and association with mortality compared with ketamine among critically ill patients
Take Home Message: Etomidate use at initiation of invasive ventilation was associated with higher hospital mortality than ketamine in this observational study, which cannot establish causation.


Respiratory support/ARDS Care

Lung-protective Ventilation

ARMA
Take Home Message: Ventilation with approximately 6 rather than 12 mL/kg predicted body weight reduced mortality in acute lung injury and ARDS.

ALVEOLI
Take Home Message: Higher and lower PEEP strategies produced similar survival and ventilator-free days when both used low tidal volumes in acute lung injury and ARDS.

EPVent-2
Take Home Message: Esophageal-pressure-guided PEEP did not improve the composite of death and ventilator-free days compared with an empirical high-PEEP strategy in moderate-to-severe ARDS.

PROSEVA
Take Home Message: Early prolonged prone positioning substantially reduced mortality in patients with severe ARDS receiving lung-protective ventilation.

ACURASYS
Take Home Message: Early 48-hour cisatracurium improved adjusted 90-day survival in severe ARDS, although the unadjusted mortality difference was not statistically significant.

ROSE
Take Home Message: Routine early neuromuscular blockade with deep sedation did not improve 90-day survival compared with usual care using lighter sedation in moderate-to-severe ARDS.

LUNG SAFE
Take Home Message: ARDS was common, frequently underrecognized, and often managed without recommended protective strategies in this international observational study.


VV ECMO

CESAR
Take Home Message: Referral to an ECMO-capable center improved six-month survival without severe disability in severe respiratory failure, although the trial tested a care strategy rather than ECMO alone.

EOLIA
Take Home Message: Early VV ECMO did not significantly reduce the primary outcome of 60-day mortality in very severe ARDS, with substantial crossover to rescue ECMO.

Bayesian analysis of EOLIA
Take Home Message: A post hoc Bayesian analysis suggested a high probability of mortality benefit from early ECMO in very severe ARDS, with the estimate dependent on prior assumptions.


Weaning and Post-extubation Care

TRAC MAN
Take Home Message: Early tracheostomy did not improve 30-day survival compared with a deferred strategy, and many patients in the deferred group never required tracheostomy.

Postextubation HFNC/NIV
Take Home Message: Prophylactic NIV alternating with high-flow nasal oxygen reduced reintubation compared with high-flow nasal oxygen alone in patients at high risk of extubation failure.

TEAM
Take Home Message: Increasing early active mobilization during mechanical ventilation did not improve days alive and out of hospital and increased adverse events.

FAST
Take Home Message: Neither more frequent readiness screening nor pressure-supported rather than T-piece spontaneous breathing trials independently shortened time to successful extubation, with an unexpected interaction between interventions.


Oxygenation Targets

HOT-ICU
Take Home Message: Targeting a PaO2 of 60 rather than 90 mm Hg did not reduce 90-day mortality in adults with acute hypoxemic respiratory failure.

Oxygen-ICU
Take Home Message: Conservative oxygen therapy reduced ICU mortality in this single-center trial stopped early, leaving substantial uncertainty about the size and generalizability of benefit.

ICU ROX
Take Home Message: Conservative oxygen therapy did not increase ventilator-free days compared with usual oxygen therapy in mechanically ventilated adults.

BOX
Take Home Message: Restrictive and liberal oxygen targets produced similar rates of death or severe neurologic disability after out-of-hospital cardiac arrest.

PILOT
Take Home Message: Lower, intermediate, and higher oxygen-saturation targets produced similar ventilator-free days in mechanically ventilated adults.


Nutrition/GI

TARGET
Take Home Message: Energy-dense enteral nutrition increased calorie delivery but did not improve 90-day survival in mechanically ventilated adults.

PERMIT
Take Home Message: Permissive underfeeding and standard enteral feeding produced similar 90-day mortality when protein intake was comparable.

EPANIC
Take Home Message: Deferring supplemental parenteral nutrition until day 8 led to faster recovery and fewer infections than starting it early in critically ill adults.

EDEN
Take Home Message: Initial trophic and full enteral feeding produced similar ventilator-free days and survival in acute lung injury, with less gastrointestinal intolerance during trophic feeding.

Supplementary parenteral nutrition trial
Take Home Message: Supplemental parenteral nutrition on days 4–8 reduced subsequent nosocomial infections in selected ICU patients whose enteral intake remained below target.

SUP-ICU
Take Home Message: Pantoprazole reduced clinically important gastrointestinal bleeding but did not improve 90-day survival in ICU patients at risk of gastrointestinal bleeding.

PEPTIC
Take Home Message: A proton-pump-inhibitor strategy reduced clinically important upper gastrointestinal bleeding compared with H2 blockers but did not significantly reduce hospital mortality.


Renal Failure and Dialysis

AKIKI
Take Home Message: An early dialysis strategy did not improve 60-day survival in severe AKI without urgent indications, and many patients assigned to delay avoided dialysis.

STARRT-AKI
Take Home Message: Accelerated renal-replacement therapy did not improve 90-day survival and increased dialysis dependence among survivors compared with a standard strategy in severe AKI.

IDEAL-ICU
Take Home Message: Early renal-replacement therapy did not improve 90-day survival compared with a delayed strategy in septic shock with severe AKI, and the trial stopped early for futility.

RENAL
Take Home Message: Higher-intensity continuous renal-replacement therapy did not improve 90-day survival compared with a lower-intensity regimen in critically ill patients with AKI.

AKIKI2
Take Home Message: Further postponing dialysis beyond an already delayed strategy did not increase dialysis-free days and raised concern for increased mortality in severe AKI.

PLUS
Take Home Message: Balanced multielectrolyte solution did not reduce 90-day mortality or new renal-replacement therapy compared with saline in critically ill adults.

ICRAKI (2026): Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury
Take Home Message: Initial intermittent hemodialysis failed to establish noninferiority to continuous therapy for 90-day major adverse kidney events and was associated with higher mortality in this trial stopped early.


Transfusion

TRICS III
Take Home Message: A restrictive transfusion threshold of 7.5 g/dL was noninferior to a liberal strategy for death or major organ complications after cardiac surgery.

FOCUS
Take Home Message: A liberal transfusion threshold of 10 g/dL did not improve survival or walking independence compared with a restrictive strategy after hip-fracture surgery in patients with cardiovascular risk.

TRISS
Take Home Message: A hemoglobin threshold of 7 rather than 9 g/dL reduced transfusions without a significant difference in 90-day mortality among patients with septic shock.

Transfusion strategies in upper GI bleeding
Take Home Message: A restrictive transfusion threshold of 7 rather than 9 g/dL improved six-week survival and reduced rebleeding in selected patients with acute upper gastrointestinal bleeding.

REALITY
Take Home Message: Restrictive transfusion met the trial’s noninferiority criterion for 30-day major cardiovascular events in acute myocardial infarction with anemia, but the confidence interval allowed clinically important harm.

PROPPR
Take Home Message: A 1:1:1 plasma:platelet:red-cell ratio did not significantly reduce overall mortality versus 1:1:2 in severe trauma but improved hemostasis and reduced early exsanguination deaths.


Endocrine

NICE SUGAR
Take Home Message: Intensive glucose control targeting 81–108 mg/dL increased mortality and severe hypoglycemia compared with conventional control in critically ill adults.


Infectious Disease

STOP-IT
Take Home Message: About four days of antibiotics after adequate source control produced similar outcomes to a longer course for complicated intra-abdominal infection.

MERINO
Take Home Message: Piperacillin-tazobactam failed to demonstrate noninferiority to meropenem for 30-day mortality in ceftriaxone-resistant E. coli or Klebsiella bloodstream infection.

PROGRESS
Take Home Message: Procalcitonin-guided antibiotic discontinuation reduced antibiotic duration and infection-associated adverse events in sepsis in this randomized trial.


Palliative Care

RCT of family-support intervention in ICUs
Take Home Message: A structured ICU family-support intervention improved perceived communication and patient-centeredness but did not reduce surrogate decision-makers’ anxiety and depression at six months.


Healthcare Disparities in Critical Illness

Association of Race and Ethnicity with COVID-19 Test Positivity and Hospitalization Is Mediated by Socioeconomic Factors
Take Home Message: Socioeconomic factors substantially mediated associations between race or ethnicity and COVID-19 test positivity and hospitalization in this observational study.

Racial bias in pulse oximetry
Take Home Message: Pulse oximetry missed arterial hypoxemia more often in Black than White patients in two retrospective cohorts, revealing an important limitation of oxygen-saturation monitoring.

Patient and Hospital Factors Associated With Differences in Mortality Rates Among Black and White US Medicare Beneficiaries Hospitalized With COVID-19 Infection
Take Home Message: Differences between hospitals largely accounted for the adjusted Black–White disparity in death or hospice discharge among Medicare patients hospitalized with COVID-19.

Temporal Trends in Critical Care Outcomes in U.S. Minority-Serving Hospitals
Take Home Message: Mortality improvements were smaller in minority-serving ICUs than in other hospitals over a decade, especially for Black patients, in this observational cohort.

Racial Variation in End-of-Life Intensive Care Use: A Race or Hospital Effect?
Take Home Message: Most observed racial and ethnic differences in end-of-life ICU use reflected which hospitals patients attended rather than differences within the same hospital.

Genetic misdiagnoses and the potential for health disparities
Take Home Message: Underrepresentation of people with African ancestry in genetic reference datasets contributed to misclassification of benign variants as pathogenic, illustrating how unrepresentative data can cause diagnostic inequity.